ENSG · The Ensign Group, Inc.

The Ensign Group’s Q1 2026 results reflect robust organic growth and disciplined capital deployment, with GAAP diluted EPS of $1.67 (+21.9% YoY) and adjusted EPS of $1.85 (+21.7% YoY), both exceeding prior-year performance. Revenue grew 18.4% YoY to $1.39 billion, driven by a 22-operation expansion completed during the quarter—including 21 real estate assets—and strong same-facility metrics: Same Facilities occupancy rose to 84.3% (+2.3 pts YoY) and skilled days increased 4.4%, while Medicare revenue improved 9.8%. The Standard Bearer real estate segment contributed $36.1 million in rental revenue (+27.1% YoY) and $21.6 million in FFO (+26.6% YoY), with 137 of its 173 owned properties leased to Ensign affiliates under triple-net leases—underscoring the scalability and resilience of its vertically integrated model. Management attributed performance to clinical excellence, evidenced by CMS survey and 5-Star Quality Measure outperformance versus peers, and a diversified payor base that mitigated regional reimbursement volatility. Critically, the company raised full-year 2026 EPS guidance to $7.48–$7.62 (midpoint +15% vs. 2025), citing Q1 strength and expected closings of additional acquisitions through Q2. Liquidity remains ample ($539.5M cash + $591.6M undrawn revolver), supporting continued dividend payments ($0.065/share) and strategic flexibility. The guidance increase—though modest in range—signals confidence in sustained operating leverage, acquisitive capacity, and the durability of its local leadership model across geographies and care settings.